| Code | Description | Claims | Beneficiaries | Total Paid |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,836 |
1,318 |
$69K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,224 |
1,037 |
$40K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,091 |
972 |
$27K |
| 87634 |
|
1,550 |
1,101 |
$25K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,461 |
1,213 |
$20K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
348 |
288 |
$17K |
| 87581 |
|
1,230 |
1,035 |
$16K |
| 87481 |
|
110 |
95 |
$8K |
| 87640 |
|
556 |
440 |
$8K |
| 87641 |
|
390 |
323 |
$6K |
| 87529 |
|
164 |
123 |
$4K |
| 87498 |
|
194 |
179 |
$3K |
| 87486 |
|
194 |
179 |
$3K |
| 87511 |
|
161 |
123 |
$2K |
| 87500 |
|
104 |
97 |
$2K |
| 87653 |
|
109 |
94 |
$2K |
| 87541 |
|
70 |
61 |
$933.41 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
77 |
69 |
$680.75 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
77 |
69 |
$645.66 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
77 |
69 |
$631.67 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
65 |
49 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
165 |
99 |
$0.00 |